NetScientific’s subsidiary Wanda has signed a deal with a US hospital group Dignity Health to launch a digital health oncology care platform, OncoVerse.
OncoVerse is a digital healthcare platform that will enable Dignity Health’s medical professionals to make informed oncological treatment decisions.
Go deeper with GlobalData
The platform will expand the geographic reach of its clinical decision-making support system to rural and remote areas, allowing all patients to benefit from insights.
It also allows the medical professionals to highlight the cancer related cases for evidence-based peer collaboration, review, treatment recommendations and second opinions that are available 24/7 from any computer or other web-enabled device.
Wanda and Dignity Health is said to jointly market the Oncoverse platform to other oncology programmes across the US later this year.
The agreement will also facilitate a cross-marketing of existing and future Wanda products.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataNetScientific CEO Francois Martelet said: "Wanda is the Group’s lead subsidiary in our digital health franchise.
"The launch of Oncoverse with Dignity Health, and its huge US network, is a significant milestone for the company and further endorses its core technology.
"This deal marks the second partnership that Wanda has secured with a leading US healthcare group since the start of 2016 as it continues to develop more platforms to better manage chronic conditions."
Last month, Wanda signed a deal with Chicago-based Health Resource Solutions (HRS), to supply its chronic condition digital management system to monitor patients, observe symptoms and control the chances of hospitalisations.
